Partnering Overview


Partnering

Neurokos recognizes the value of collaborating with partners who share our commitment and passion in bringing novel therapies to patients.


Outlicensing

Neurokos is looking for partners to co-develop and commercialize its clinical stage neurology pipeline. We are looking for collaborators for the following program(s) at this point:

  • Neurokos' Clinical stage, First-in-class, Disease modifying program for Alzheimer's disease

Please contact partnering@neurokos.com for more information on this opportunity.

Inlicensing

Neurokos is seeking to in-license compounds that are in preclinical or early clinical development. Our current areas of therapeutic focus within neurology include neurodegenerative diseases and pain.

Please contact partnering@neurokos.com with in-licensing opportunities.